title: Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes.
abstract: OBJECTIVE
  Salvage robotic assisted laparoscopic radical prostatectomy (SRALP) has now become a feasible alternative to open prostatectomy in experienced hands. Herein we review the urologic literature for the indications and outcomes of SRALP.
  
  
  METHODS
  A comprehensive review of the peer reviewed literature was performed for reported cases of salvage robotic and open prostatectomy, with emphasis being on comparing oncologic outcomes.
  
  
  RESULTS
  Salvage prostatectomy, whether open or robotic, is a viable alternative for treatment of recurrent, localized, non-metastatic prostate cancer after failed primary radiotherapy. Although few reports of salvage robotic prostatectomy have been published with limited long-term follow-up, initial oncologic results seem at least comparable to the salvage open prostatectomy series. SRALP should be performed by centers with a dedicated and well experienced robotic urologic oncology program.
  
  
  CONCLUSIONS
  SRALP is a feasible surgical treatment option for patients with recurrence after primary radiotherapy with preliminary oncologic outcomes comparable to the open approach. Further long-term follow-up is needed to validate these results.
authors.affiliation: Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 20015, USA. swilliams22@partners.org
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Williams
authors.forename: Jim C
authors.initials: JC
authors.lastname: Hu
mesh_terms: D001706:Biopsy; D007172:Erectile Dysfunction / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D008297:Male; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery*; D012371:Robotics / Q000379:methods*; D016879:Salvage Therapy / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000453:epidemiology